Literature DB >> 25409699

Phosphatidylethanolamine plasmalogen enhances the inhibiting effect of phosphatidylethanolamine on γ-secretase activity.

Tomoko Onodera1, Eugene Futai1, Eiichiro Kan1, Naoki Abe1, Takafumi Uchida1, Yoshiyuki Kamio1, Jun Kaneko2.   

Abstract

Plasmalogens (Pls) are widely distributed in the biological membrane of animals and certain anaerobic bacteria, but their functions in the cell membrane are still poorly understood. Decrease of phosphatidylethanolamine plasmalogen (PEPls) in the brain tissue of patients with Alzheimer's disease prompted us to investigate the effect of the membrane phosphorus lipid composition on the activity of γ-secretase that produces amyloid-beta protein (Aβ). To clarify the effect of phospholipids, including PEPls, on Aβ production, γ-secretase activity was measured in an in vitro assay using yeast microsomes and reconstituted liposomes. The presence of ethanolamine phospholipids in the proteoliposome weakened γ-secretase activity. In addition, increased PEPls content in total ethanolamine phospholipids further decreased the enzyme activity, indicating that γ-secretase activity is affected by the membrane phospholipid PEPls/PE ratio. Furthermore, PEPls from anaerobic bacterial cell membrane induced the same effect on γ-secretase activity.
© The Authors 2014. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; amyloid-beta; phosphatidylethanolamine plasmalogen; yeast microsomes; γ-secretase activity

Mesh:

Substances:

Year:  2014        PMID: 25409699     DOI: 10.1093/jb/mvu074

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport.

Authors:  Brian W Kunkle; Badri N Vardarajan; Adam C Naj; Patrice L Whitehead; Sophie Rolati; Susan Slifer; Regina M Carney; Michael L Cuccaro; Jeffery M Vance; John R Gilbert; Li-San Wang; Lindsay A Farrer; Christiane Reitz; Jonathan L Haines; Gary W Beecham; Eden R Martin; Gerard D Schellenberg; Richard P Mayeux; Margaret A Pericak-Vance
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

Review 2.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

3.  Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Authors:  Shengyuan Luo; Josef Coresh; Adrienne Tin; Casey M Rebholz; Lawrence J Appel; Jingsha Chen; Ramachandran S Vasan; Amanda H Anderson; Harold I Feldman; Paul L Kimmel; Sushrut S Waikar; Anna Köttgen; Anne M Evans; Andrew S Levey; Lesley A Inker; Mark J Sarnak; Morgan Erika Grams
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-07       Impact factor: 8.237

4.  Oral Administration of Ethanolamine Glycerophospholipid Containing a High Level of Plasmalogen Improves Memory Impairment in Amyloid β-Infused Rats.

Authors:  Shinji Yamashita; Michio Hashimoto; Abdul Md Haque; Kiyotaka Nakagawa; Mikio Kinoshita; Osamu Shido; Teruo Miyazawa
Journal:  Lipids       Date:  2017-05-27       Impact factor: 1.880

5.  Analysis of Plasmalogen Species in Foodstuffs.

Authors:  Shinji Yamashita; Susumu Kanno; Ayako Honjo; Yurika Otoki; Kiyotaka Nakagawa; Mikio Kinoshita; Teruo Miyazawa
Journal:  Lipids       Date:  2016-01-05       Impact factor: 1.880

6.  Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Takehiko Fujino; Tatsuo Yamada; Takashi Asada; Yoshio Tsuboi; Chikako Wakana; Shiro Mawatari; Suminori Kono
Journal:  EBioMedicine       Date:  2017-02-24       Impact factor: 8.143

Review 7.  APP Function and Lipids: A Bidirectional Link.

Authors:  Marcus O W Grimm; Janine Mett; Heike S Grimm; Tobias Hartmann
Journal:  Front Mol Neurosci       Date:  2017-03-10       Impact factor: 5.639

Review 8.  Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer.

Authors:  Márcia Cristina Fernandes Messias; Giovana Colozza Mecatti; Denise Gonçalves Priolli; Patrícia de Oliveira Carvalho
Journal:  Lipids Health Dis       Date:  2018-03-07       Impact factor: 3.876

Review 9.  Lipids and Alzheimer's Disease.

Authors:  Yu-Chia Kao; Pei-Chuan Ho; Yuan-Kun Tu; I-Ming Jou; Kuen-Jer Tsai
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

10.  The TMEM189 gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens.

Authors:  Ernst R Werner; Markus A Keller; Sabrina Sailer; Katharina Lackner; Jakob Koch; Martin Hermann; Stefan Coassin; Georg Golderer; Gabriele Werner-Felmayer; Raphael A Zoeller; Nicolas Hulo; Johannes Berger; Katrin Watschinger
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-24       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.